☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
DCGI
Zydus' ZyCoV-D Receives the DCGI's EUA for the Treatment of COVID-19
August 23, 2021
Zydus' Saroglitazar Receives DCGI's Approval as the World's First Therapy for Non-Cirrhotic NASH in India
March 6, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.